首页 | 本学科首页   官方微博 | 高级检索  
检索        

疏血通与凯时联合治疗慢性肾功能衰竭的临床观察
引用本文:张建国,任姜汶,李展旭,杨聚荣.疏血通与凯时联合治疗慢性肾功能衰竭的临床观察[J].中国医药导报,2006,3(24):28-29.
作者姓名:张建国  任姜汶  李展旭  杨聚荣
作者单位:第三军医大学附属大坪医院,重庆,400042
摘    要:目的观察疏血通与凯时联合治疗慢性肾功能衰竭(CRF)的临床疗效。方法98名CRF氮质血症期患者,随机分为治疗组和对照组。在常规治疗基础上,治疗组采用疏血通及凯时联合治疗,而对照组仅予常规治疗,治疗前后检测24小时尿蛋白的定量(UP)、血肌酐(Scr)、内生肌酐清除率(Ccr)、血脂(CH、TG)及血液流变学参数。结果疗程结束后治疗组UP、Scr、CH、TG均较治疗前显著降低。Ccr显著升高,血液流变学参数亦较治疗前显著改善,而对照组治疗前后各观测指标无显著统计学差异。且治疗组治疗中无发生严重不良反应。结论对于CRF氮质血症期患者,在常规治疗基础上,应用疏血通与凯时联合治疗是一种安全有效的治疗手段,值得临床推广应用。

关 键 词:疏血通  凯时  肾功能衰竭
修稿时间:2006年7月15日

A clinical study on the effect of Shuxue Tong and Lipo PGE_1 in chronic renal failure patients
Zhang Jianguo,Ren Jiangwen,Li Zhanxu,et al.A clinical study on the effect of Shuxue Tong and Lipo PGE_1 in chronic renal failure patients[J].China Medical Herald,2006,3(24):28-29.
Authors:Zhang Jianguo  Ren Jiangwen  Li Zhanxu  
Abstract:Objective To study the clinical effects of Shuxue Tong and Lipo PGE1 in chronic renal failure patients.Methods 98 patients with chronic renal failure were randomly divided into treatment group and contral group.Patients in treatment group were treated with Shuxue Tong and lipo PGE1 injection,while in control group with routine therapy.UP?Scr?Ccr?CH?TG and hemorheology were measured.Results After treatment all parameters were inproved in treatment groups,and there were no significant difference in control groups.There were no severe side reactions in treated groups.Conclusions Shuxue Tong and Lipo PGE1 injection,with its satefy and reliability,has been proved clinical benefits for chronic renal failure patients in meliorate prognosis.
Keywords:Shuxue Tong  Lipo PGE1  Renal Failure
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号